Tuesday, May 22, 2018

After CNN report, lawmakers want answers from Uber, Lyft on sexual assaults

Lawmakers are demanding answers from ridesharing companies about sexual violence on their platforms.

Nine members of Congress sent a letter to the CEOs of Uber, Lyft, Juno, Curb, and Via on Monday requesting details about their protocols related to sexual assault and harassment reports, training drivers, and more.

The letter, first seen by CNN, came following a recent CNN investigation that found at least 103 Uber drivers in the United States have been accused of sexually assaulting or abusing their passengers in the past four years.

"The questions we're asking are, in many senses, common sense questions that we'd hope the ridesharing companies would already be doing, like maintaining records of driver who've been accused of sexual violence," said Democratic Caucus Chairman Joe Crowley of New York, who drafted the letter along with Congresswoman Lois Frankel of Florida. "[CNN's] article really begged these questions in many respects."

Read the letter: Lawmakers demand answers over rideshare driver assaults

The letter asks if the companies maintain records on drivers who've been accused of sexual violence and do they make that information public. It also wants to know if the companies have protocols in place to alert other ridesharing companies if drivers on their platform are reported for harassment or discrimination. Drivers often work for multiple companies.

"I have a [17-year-old] daughter, and I want her to know that when she's going to and from a place, she should be safe and not assaulted or sexually attacked," Crowley said in a phone interview. "Regardless of what condition the individual was in during a ride, they have every right to expect that they're treated with respect, dignity and honor."

Many of the women who say they were raped or attacked by the 103 accused drivers uncovered as a part of CNN's investigation had been drinking, or were inebriated, at the time of the incidents.

CNN's analysis came from an in-depth review of police reports, federal court records and county court databases for 20 major US cities. At least 31 of the Uber drivers have been convicted for crimes ranging from forcible touching and false imprisonment to rape, and dozens of criminal and civil cases are pending, CNN found.

Lyft, Uber's biggest US competitor, had 18 cases of its drivers accused of sexual assault or abuse in the past four years, according to a similar CNN review using the same methodology found. Drivers were either arrested, are wanted by police, or have been named in civil suits related to the incidents. Four Lyft drivers have been convicted.

CNN found two instances in which drivers pleaded guilty to sexual assaults while working for both Uber and Lyft.

Uber passenger alleging rape speaks Uber passenger alleging rape speaks

Five Uber drivers across various states told CNN as part of the investigation that they were not provided any kind of sexual harassment or assault training. Drivers agree to the company's community guidelines when they sign up to work for the service. Uber said it updated its standards in December 2016 to specify no sexual contact is permitted when using its platform.

The letter puts new pressure on the companies to be transparent about their internal protocols and safety measures pertaining to sexual violence.

"We do expect [the companies] to respond in a very forthright way," said Crowley. "It may very well -- depending on the answers they give -- require additional investigating, additional reporting, and at some point, a possible hearing."

The inquiries from the lawmakers are similar to questions CNN pressed Uber and Lyft on as part of the investigation.

Neither company disclosed data on the number of reports received from riders, but both promised last week to publish data in the future.

"We want to bring these numbers out in the open. We want people to acknowledge the enormity of the issue, and we want us to begin to think of constructive ways to prevent and end sexual assault," said Tony West, Uber's chief legal officer, told CNN last week.

The companies also agreed to stop forcing survivors into arbitration and will no longer require confidentiality as a part of settlements. However, survivors won't be able to pursue class action lawsuits.

"Eliminating forced arbitration and making confidentiality an option for survivors are good steps forward. There's more work to be done to ensure safety and fairness," said Frankel in a statement to CNN.

But Crowley also praised some of the recent updates Uber has made to commit to safety. In April, the company said it was tightening its background check processes and rerunning background checks annually.

Although the letter doesn't give a deadline for the CEOs to respond, Crowley said, "We expect a response within a reasonable amount of time."

-- CNN's Nelli Black, Curt Devine, Drew Griffin, Majlie de Puy Kamp, Collette Richards and Whitney Clegg contributed reporting.

Monday, May 21, 2018

Zacks: Brokerages Anticipate Uniqure NV (QURE) Will Announce Quarterly Sales of $3.55 Million

Analysts forecast that Uniqure NV (NASDAQ:QURE) will report sales of $3.55 million for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Uniqure’s earnings, with estimates ranging from $3.50 million to $3.60 million. Uniqure posted sales of $4.94 million during the same quarter last year, which would indicate a negative year over year growth rate of 28.1%. The firm is scheduled to report its next earnings report on Tuesday, August 14th.

On average, analysts expect that Uniqure will report full year sales of $17.44 million for the current fiscal year, with estimates ranging from $13.98 million to $26.00 million. For the next fiscal year, analysts expect that the firm will report sales of $13.23 million per share, with estimates ranging from $10.00 million to $16.90 million. Zacks’ sales calculations are a mean average based on a survey of sell-side research firms that cover Uniqure.

Get Uniqure alerts:

Uniqure (NASDAQ:QURE) last announced its quarterly earnings results on Monday, April 30th. The biotechnology company reported ($0.59) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.74) by $0.15. The firm had revenue of $3.48 million during the quarter, compared to the consensus estimate of $3.08 million. Uniqure had a negative return on equity of 131.55% and a negative net margin of 586.38%.

A number of brokerages recently issued reports on QURE. ValuEngine raised Uniqure from a “hold” rating to a “buy” rating in a report on Monday, April 2nd. HC Wainwright set a $35.00 price objective on Uniqure and gave the company a “buy” rating in a report on Tuesday, May 1st. Leerink Swann reissued an “outperform” rating and issued a $63.00 price objective (up from $26.00) on shares of Uniqure in a report on Monday, May 7th. BidaskClub downgraded Uniqure from a “buy” rating to a “hold” rating in a report on Saturday, March 17th. Finally, Wells Fargo assumed coverage on Uniqure in a report on Wednesday, May 16th. They issued an “outperform” rating and a $47.00 price objective for the company. Two equities research analysts have rated the stock with a hold rating, seven have given a buy rating and two have given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $30.88.

In other news, CEO Matthew C. Kapusta sold 39,169 shares of the stock in a transaction that occurred on Thursday, March 15th. The stock was sold at an average price of $21.72, for a total value of $850,750.68. Following the completion of the sale, the chief executive officer now directly owns 439,764 shares of the company’s stock, valued at $9,551,674.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.73% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Opaleye Management Inc. acquired a new stake in shares of Uniqure during the fourth quarter worth $1,778,000. Royce & Associates LP acquired a new stake in shares of Uniqure during the fourth quarter worth $2,449,000. Victory Capital Management Inc. acquired a new stake in shares of Uniqure during the fourth quarter worth $1,298,000. Perceptive Advisors LLC lifted its holdings in shares of Uniqure by 0.8% during the fourth quarter. Perceptive Advisors LLC now owns 1,047,950 shares of the biotechnology company’s stock worth $20,529,000 after purchasing an additional 7,831 shares during the period. Finally, Tekla Capital Management LLC lifted its holdings in shares of Uniqure by 38.1% during the fourth quarter. Tekla Capital Management LLC now owns 332,850 shares of the biotechnology company’s stock worth $6,521,000 after purchasing an additional 91,829 shares during the period. 43.83% of the stock is owned by hedge funds and other institutional investors.

Uniqure traded up $0.07, reaching $31.38, on Friday, according to Marketbeat. The company’s stock had a trading volume of 14,294 shares, compared to its average volume of 390,560. The company has a quick ratio of 5.48, a current ratio of 5.48 and a debt-to-equity ratio of 0.16. The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of -10.71 and a beta of 0.15. Uniqure has a fifty-two week low of $4.90 and a fifty-two week high of $33.41.

About Uniqure

uniQure N.V., a gene therapy company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company develops AMT-060, which is in Phase I/II clinical trial to treat hemophilia B; AMT-061, a gene therapy that is in Phase III clinical trial for the treatment of hemophilia; and AMT-126, a gene therapy for the treatment of congestive heart failure and AMT-130 to treat huntington's disease.

Get a free copy of the Zacks research report on Uniqure (QURE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Uniqure (NASDAQ:QURE)